from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3473c/bpoA

LFCtreatmentdescriptionclass of inhibitor

0.111

Amikacinug/mL Amikacintranslation

0.001

Cap5-10ug/mL Capreomycintranslation

0.363

Rox10-50 ug/mL Roxithromycintranslation

0.455

SM2-5 ug/mL Streptomycintranslation

0.045

Tet5-10 ug/mL Tetracyclinetranslation

0.174

Rif0.2-5ug/mL Rifampicintranscription

0.331

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.044

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.341

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.082

CPZ10-50 ug/mL Chlorpromazinerespiration

1.471

Clofazimine10-13 ug/mL Clofaziminerespiration

0.884

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.295

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.582

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.394

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.905

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.427

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.551

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.105

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.009

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.822

Nigericin50 uM Nigericinrespiration

-0.083

TRC10-150 ug/mL Triclosanrespiration

0.751

TRZ10-25 ug/mL Thioridazinerespiration

-0.017

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.023

menadione6-10 ug/mL Menadionerespiration

0.042

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.191

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.269

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.144

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.123

NRP_1Non-replicating persistence stage 1dosRassociated

-0.336

Amp0.2mg/mL AmpicillincellWall

-0.070

Cephalexin20-100 ug/mL CephalexincellWall

-0.010

Cerulenin0.32-5 ug/mL CerulenincellWall

0.089

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.385

EMB10-20 ug/mL EthambutolcellWall

-0.067

Eta12-40 ug/mL EthionamidecellWall

0.088

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.140

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.004

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.003

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.577

BZA0.12 mg/mL BenzamidearomaticAmides

-0.049

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.105

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.185

H2O24 mM hydrogen peroxideDNAdamaging

-0.057

Levo10 ug/mL LevofloxacinDNAdamaging

-0.710

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.528

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.089

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.756

UVUV-irradiationDNAdamaging

-0.924

ARP41-4 ug/mL Antitubercular compound ARP4?

0.756

Antimycin12.5-50 ug/mL Antimycin A?

-1.497

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.152

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.151

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.797

PA8240.2-2 ug/mL PA-824?

1.312

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.536

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.791

Verapamil50 uM Verapamil?

-0.638

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.751

methoxatin10-20 ug/mL Methoxatin?